Skip to main content
Fig. 1 | Lipids in Health and Disease

Fig. 1

From: Main differences between two highly effective lipid-lowering therapies in subclasses of lipoproteins in patients with acute myocardial infarction

Fig. 1

Flowchart. Only patients with a first myocardial infarction (STEMI) undergoing pharmacological thrombolysis during the first 6 h and coronary angiogram followed when necessary by percutaneous coronary intervention in the first 24 h were included. Patients receiving lipid-lowering or immunosuppressive therapy and those with clinical instability and contraindications or known intolerances for the lipid-lowering drugs of the study were excluded. One patient died during the first month after myocardial infarction

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X